LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours ...

Presbyopia is a common variant of farsightedness affecting over 128 million people in the US, including the majority of ...

A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.

The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz Therapeutics.Once-daily Vizz (aceclidine ophthalmic solution 1.44%) contracts the iris ...

Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you get older. It's the first ...

VIZZ was well-tolerated with no serious adverse events observed in the 30,000-plus treatment days across all three trials. Presbyopia is, unfortunately, an inevitable condition associated with aging.

Vizz (aceclidine), is an eye drop designed to help people who have presbyopia, which is a decline in your eye's ability to focus clearly on things close to you. Things at a distance may or may not ...